Showing results (271-280 of 484) with videos related to
Sort By:
Pageof 49
Biochimica Et Biophysica Acta|July 6, 1987
Variations among cultured cells in glutathione peroxidase activity in response to selenite supplementationB E Sandström, J Carlsson, S L MarklundThrombosis Research|June 11, 2011
Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY studyS M Schellong, H-E Gerlach, U Tebbe, et al.European Heart Journal|July 1, 1995
Recombinant hirudin and front-loaded alteplase in acute myocardial infarction: final results of a pilot study. HIT-I (hirudin for the improvement of thrombolysis)U Zeymer, R von Essen, U Tebbe, et al.Journal of the American College of Cardiology|August 1, 1995
Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With SaruplaseU Tebbe, J Windeler, I Boesl, et al.Circulation|October 1, 1994
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)K L Neuhaus, R von Essen, U Tebbe, et al.Thrombosis and Haemostasis|April 21, 2011
CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiencyR Bauersachs, S M Schellong, S Haas, et al.Journal of the American College of Cardiology|April 1, 1992
Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)K L Neuhaus, R von Essen, U Tebbe, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1975
A rapid and specific method for isolation of thiol-containing peptides from large proteins by thiol-disulfide exchange on a solid supportT A Egorov, A Svenson, L Rydén, et al.Infection and Immunity|September 1, 1989
Activity of polymorphonuclear leukocytes in the presence of sulfideR Claesson, M Granlund-Edstedt, S Persson, et al.Physics in Medicine and Biology|March 28, 2008
Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristicsS A Enger, T Hartman, J Carlsson, et al.Pageof 49